ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
122.13
+3.41 (2.87%)
May 18, 2026, 4:00 PM EDT - Market closed
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1.28B | 1.36B | 1.53B | | | | | | | | |
United States Revenue Growth | -5.36% | -11.49% | 6.39% | | | | | | | | |
Europe, Middle East and Africa Revenue | 420.67M | 411.68M | 393.53M | | | | | | | | |
Europe, Middle East and Africa Revenue Growth | 2.18% | 4.61% | 5.34% | | | | | | | | |
| 231.79M | 232.90M | 232.82M | | | | | | | | |
| -0.48% | 0.04% | -3.67% | | | | | | | | |
Other Foreign Countries Revenue | 220.95M | 230.56M | 223.59M | | | | | | | | |
Other Foreign Countries Revenue Growth | -4.17% | 3.12% | 9.69% | | | | | | | | |
Total Other Foreign Countries Revenue | 452.74M | 463.46M | 456.41M | | | | | | | | |
Total Other Foreign Countries Revenue Growth | -2.31% | 1.54% | 2.44% | | | | | | | | |
| 7.00K | 2.00K | 8.00K | | | | | | | | |
| 2.16B | 2.23B | 2.38B | | | | | | | | |
| -3.34% | -6.33% | 5.44% | | | | | | | | |
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1.12B | 1.11B | 1.04B | | | | | | | | |
Consumables Revenue Growth | 1.09% | 6.76% | 7.20% | | | | | | | | |
Infusion Systems Revenue (Post-FY2022 Reporting) | 697.51M | 684.21M | 652.41M | | | | | | | | |
Infusion Systems Revenue (Post-FY2022 Reporting) Growth | 1.94% | 4.87% | 3.72% | | | | | | | | |
| 338.09M | 437.92M | 690.77M | | | | | | | | |
Vital Care Revenue Growth | -22.80% | -36.60% | 4.51% | | | | | | | | |
| 4.00K | -2.00K | 3.00K | | | | | | | | |
| 2.16B | 2.23B | 2.38B | | | | | | | | |
| -3.34% | -6.33% | 5.44% | | | | | | | | |
Updated May 7, 2026. Data Source:
Fiscal.ai.